The Food and Drug Administration approved Nplate for patients with a disorder that causes the body to attack its own platelets, tiny components of blood that help with clotting.
The Food and Drug Administration approved Nplate for patients with a disorder that causes the body to attack its own platelets, tiny components of blood that help with clotting.
Bayer’s experimental anticoagulant Xarelto, its biggest new drug hope, has been recommended for approval by the European Medicines Agency.
The American Red Cross is finding that a little corporate sponsorship — plus a few freebies — helps to coax people to roll up their sleeves.
The American Red Cross is finding that a little corporate sponsorship — plus a few freebies — helps to coax people to roll up their sleeves.